A licensed provider can explain the risks, alternatives, and whether peptide therapy is appropriate.
Injectable Dosage (Subcutaneous or Intramuscular) Typical Range: 250500 mcg per day Administration: Inject subcutaneously near the injury site or systemically (abdomen) for full-body support Split doses (e.g., 250 mcg morning, 250 mcg evening) are common for sustained healing response Often used for 24 weeks , then cycled off or tapered depending on recovery progress BPC-157 promotes tendon outgrowth, cellular survival, and healing when administered directly into or near damaged soft tissues (Gwyer et al., Frontiers in Pharmacology)
If you get an adverse effect: what do you stop first
Individual results may vary based on health status, lifestyle, and treatment frequency
PMC 7601760
The categories described in Section 2 are the categories we may have collected during the preceding 12 months